Anita Kolnagou

Advances in the Prevention and Treatment are Changing Thalassemia from a Fatal to a Chronic Disease. Experience from a Cyprus Model and its Use as a Paradigm for Future Applications

Anita Kolnagou, George J. Kontoghiorghes · Hemoglobin · 2009 · 33 citations

Medicine, Hematology, Pharmacotherapy +17

Uses and Limitations of Serum Ferritin, Magnetic Resonance Imaging T2 and T2* in the Diagnosis of Iron Overload and in the Ferrikinetics of Normalization of the Iron Stores in Thalassemia Using the International Committee on Chelation Deferiprone/Deferoxamine Combination Protocol

Anita Kolnagou, Dilek Yazman, Charalambos Economides et al. · Hemoglobin · 2009 · 33 citations

Medicine, Hematology, Radiology +17

Risk/Benefit Assessment, Advantages Over Other Drugs and Targeting Methods in the Use of Deferiprone as a Pharmaceutical Antioxidant in Iron Loading and Non Iron Loading Conditions

George J. Kontoghiorghes, Aglaia Efstathiou, Marios Kleanthous et al. · Hemoglobin · 2009 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +16

Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus

Petros Kountouris, Kyriaki Michailidou, Soteroula Christou et al. · Haematologica · 2020 · 14 citations · Full text

Medicine, Genetics, Hematology +16